Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 4 (RPL36P4), also known as dJ477O4.3, is classified as a pseudogene, meaning it is a non-functional segment of DNA that resembles a functional gene but typically does not produce a functional protein product[2]. It is related in sequence to the ribosomal protein L36 gene (RPL36), which encodes a genuine component of the 60S ribosomal subunit; however, as a pseudogene, RPL36P4 is generally considered non-coding and not involved in cellular processes such as protein synthesis[2]. No evidence currently indicates its roles in disease, function, or as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 4 (RPL36P4).